Skip to content

CDR

Bartell Drugs appoints marketing VP

Bartell Drugs appoints marketing VP

Steven Frestedt has been promoted to vice president of marketing at Bartell Drugs. The Puget Sound, Wash.-area drug chain said Wednesday that Frestedt supervise marketing initiatives for the retailer’s 64 stores in King, Pierce and Snohomish counties.

Uniprix CEO bullish on drug chain’s prospects

Uniprix CEO bullish on drug chain’s prospects

As a drug store customer, Philippe Duval, president and chief executive officer of Uniprix Group, was always surprised by how little the trade class had changed for decades. “The reason I came out of retirement in February to head up the Uniprix Group was the fact that there were so many

Merger wave hits health insurance sector

Merger wave hits health insurance sector

Drug chains have gotten used to dealing with fewer, and larger, drug makers, wholesalers and PBMs over the years. Retailers have also consolidated. Now a merger wave has washed over the health insurance industry.

CVS Health tallies 2Q sales, earnings gains

CVS Health tallies 2Q sales, earnings gains

CVS Health saw sales climb in the second quarter and posted adjusted earnings per share in line with Wall Street’s forecast, despite the impact of costs from its pending Omnicare and Target pharmacy acquisitions. CVS said Tuesday that for the three months ended June 30, total sales rose 7.4% to $37.

Rite Aid names Martindale as CEO of stores

Rite Aid names Martindale as CEO of stores

In a reorganization of key leadership, Rite Aid Corp. has promoted president and chief operating officer Ken Martindale to the newly created position of chief executive officer of Rite Aid stores.

DenTek launches e-commerce website

DenTek launches e-commerce website

DenTek has gone live with a new branded website featuring full e-commerce capabilities. The oral care brand said Monday that DenTek.com now provides oral care product information and tips plus the ability for consumers to buy items directly through the site.

Pfizer to buy U.S. rights for potential MS generic drug

Pfizer to buy U.S. rights for potential MS generic drug

Pfizer Inc. has entered into an agreement with Synthon to acquire the exclusive U.S. commercialization rights for glatiramer acetate, a potential generic version of Teva Pharmaceuticals’ Copaxone for the treatment of relapsing remitting multiple sclerosis (RRMS).

Benzer Pharmacy serves up Rx compliance packaging

Benzer Pharmacy serves up Rx compliance packaging

Benzer Pharmacy has begun offering free med-pack preparations to customers struggling to remember to take all their medications and keep them organized. The regional drug chain said Monday that the solution employs the Dispill cold-sealed, multidose packaging system from Dispill-USA Inc.

AmerisourceBergen unveils new GNP support network

AmerisourceBergen unveils new GNP support network

At its ThoughtSpot 2015 conference, which ended this weekend, AmerisourceBergen Corp. introduced a range of new capabilities for its Pharmacy Services Administration Organization that will bolster support of its Good Neighbor Pharmacy independent pharmacy network.

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S.

Same-store sales edge up in July at Rite Aid

Same-store sales edge up in July at Rite Aid

Comparable pharmacy sales growth more than offset flat front-end results to lift Rite Aid Corp.’s same-store sales for July. Rite Aid said Thursday that for the four weeks ended July 25, comparable-store sales rose 2.4% year over year, matching the comp-store growth posted in June.